Volumetric YC-Bewerbung
Volumetric durchlief Y Combinator im Winter 2020-Batch als ein Healthcare-Unternehmen. Unten: Was das Unternehmen tut, wer es gegründet hat und seine Bewerbung bei YC, Frage für Frage im echten YC-Formular rekonstruiert.
- YC-Batch
- Winter 2020
- Branche
- HealthcareIndustrial Bio
- Teamgröße
- 5
- Status
- Acquired
- Gestartet
- 2020
Gründer
Jordan MillerCo-Founder and President
Bagrat GrigoryanCo-Founder, COO
Was Volumetric tut
About Us Volumetric is a recognized world leader in building living multicellular tissues, with a focus on replicating discrete functions of the human body for basic mechanistic biology, laboratory testing and screening, and drug development. Founded in 2018 by Bagrat Grigoryan and Jordan Miller as a spin-out from Rice University, the full potential of our work is to build whole human organ replacements for patients, made from their own cells. Our Technology and Approach We have invented a suite of breakthrough 3D bioprinting technologies, featured on the cover of Science, that can build human tissue with complex blood vessel networks. We are leveraging this technology in the short term to build patient-specific tissues for drug safety and efficacy testing. Patient cells are taken from a biopsy, added to our proprietary 3D printed tissues, and then drug compounds are injected through the blood vessel network to mimic actual drug delivery in humans. Our vision is that our technology will provide rigorous, reproducible, and predictive outcomes for patients, resulting in drastically improved outcomes for diseases like cancer. More broadly, we see the full potential of our mission as being able to produce functional tissue and organ replacements for diseased or damaged vital organs in the body such as the lung, liver, pancreas, kidney, and heart.
Volumetrics YC-Bewerbung, rekonstruiert
Y Combinator Bewerbung
Volumetric, Winter 2020 Batch. Die echten Fragen des Antrags, beantwortet aus öffentlichen Daten.
- Founders2
- Company7
- Progress7
- Idea4
- Equity3
- Curious2
- Batch Preference1
Company
Volumetric
Build living multicellular human tissues
We build living human tissues with complex blood vessel networks using proprietary 3D bioprinting technology. Our product replicates discrete human organ functions for biology research, drug testing, and drug safety screening. We take patient cells from biopsies, add them to printed tissues, and deliver drugs through built-in vessels to mimic real human responses. Long term, we aim to replace diseased organs with functional, patient-specific tissues.
We are based in Houston, TX, and the company would remain there after YC.
Houston puts us close to Rice University where our technology started and provides access to biomedical and industrial bio partners. We're rooted here and it's where our team and ecosystem are strongest.
21 weitere Antworten in der vollständigen Bewerbung
Founders, Progress, Idea, Equity, Curious, Batch Preference sind in der Vollversion. Erstelle ein kostenloses Konto, um es in YC Insights neben jedem anderen YC-Batch zu öffnen.
Häufig gestellte Fragen
Ist das die echte YC-Bewerbung von Volumetric?
Nein. Y Combinator hält eingereichte Bewerbungen privat. Dies ist eine Rekonstruktion: die echten Fragen des YC-Formulars, beantwortet aus den öffentlichen Daten von Volumetric (Veröffentlichungsnotizen, Gründerhintergründe, Produktbeschreibung). Sie zeigt, wie sich ein Unternehmen wie Volumetric bei YC präsentieren würde, nicht den Text, den sie eingereicht haben.
In welchem YC-Batch war Volumetric?
Volumetric war Teil des Y Combinator Winter 2020-Batches.
Wer hat Volumetric gegründet?
Volumetric wurde von Jordan Miller, Bagrat Grigoryan gegründet.
Was macht Volumetric?
Volumetric builds living multicellular tissues with a focus on the…
Wie lese ich die vollständige, rekonstruierte Bewerbung?
Erstelle ein kostenloses Round Funded Konto. Die vollständige 26-Antwort-Version der Bewerbung von Volumetric, und jede andere YC-Kohorte, findest du in YC Insights.
Weitere YC Startups wie Volumetric
